Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14469477 | 0.92 | KMT2A (0.58) | SMN1; SMN2KMT2AMEN1TSHRKDM4E | |
| SCHEMBL14469460 | 0.90 | KMT2A (0.51) | SMN1; SMN2TP53KMT2AMEN1TSHR | |
| SCHEMBL14469462 | 0.89 | FAAH (0.50) | KDM4EFAAHALDH1A1POLB | |
| SCHEMBL14469476 | 0.88 | FAAH (0.50) | SMN1; SMN2KMT2ATSHRKDM4EFAAH | |
| SCHEMBL14469449 | 0.88 | KMT2A (0.53) | SMN1; SMN2TP53KMT2AMEN1TSHR | |
| SCHEMBL14469562 | 0.87 | L3MBTL1 (0.47) | SMN1; SMN2TP53KMT2AMEN1TSHR | |
| SCHEMBL14469452 | 0.87 | SMN1; SMN2 (0.47) | SMN1; SMN2TP53KMT2AMEN1TSHR | |
| SCHEMBL14469568 | 0.86 | S1PR5 (0.52) | SMN1; SMN2TP53KMT2AMEN1ALDH1A1 | |
| SCHEMBL14469553 | 0.85 | KDM4E (0.61) | SMN1; SMN2TP53KMT2AMEN1TSHR | |
| SCHEMBL14469470 | 0.85 | FAAH (0.52) | SMN1; SMN2KDM4EFAAHALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007075555-A2 | COMBINATION OF AN H3 ANTAGONIST/INVERSE AGONIST AND AN APPETITE SUPPRESSANT | SCHERING CORPORATION (US) | 2007-07-05 | — | — | WO | disclosed |